Targeting the Hedgehog pathway in cancer: can the spines be smoothened?

Laurie Ailles1, Lillian L Siu

  • 1Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto, Canada.

Insights

Aberrant Hedgehog pathway signaling is implicated in various cancers. GDC-0449, a novel smoothened inhibitor, has shown proof of concept in tumors with Hedgehog pathway mutations during its initial clinical evaluation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Aberrant Hedgehog (Hh) pathway signaling is linked to the pathogenesis of numerous solid tumors and hematologic malignancies.
  • The Hedgehog pathway plays a critical role in cell growth, differentiation, and tissue repair, and its dysregulation can drive cancer development.

Purpose of the Study:

  • To evaluate the safety and efficacy of GDC-0449, a novel first-in-class smoothened (SMO) inhibitor.
  • To establish proof of concept for GDC-0449 in patients with tumors harboring Hedgehog pathway mutations.

Main Methods:

  • Phase I clinical trial of GDC-0449.
  • Assessment of safety, tolerability, and preliminary efficacy in patients with advanced malignancies.

Main Results:

  • GDC-0449 is a novel smoothened (SMO) inhibitor that has completed phase I evaluation.
  • The drug demonstrated proof of concept in tumors characterized by Hedgehog pathway mutations.

Conclusions:

  • GDC-0449 represents a promising therapeutic agent for cancers driven by aberrant Hedgehog pathway signaling.
  • Further investigation in clinical trials is warranted to confirm its efficacy and safety profile in specific cancer types.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...